5 Experimental SMA Therapies You Might Find Interesting

4. RG7800

news_18_Artboard 343 copy 350

PTC’s more developed SMA drug candidate, RG7800, is the subject of a Phase 2 trial in adult and pediatric SMA patients, but dosing was suspended and the trial was placed on clinical hold to investigate a non-clinical safety finding observed in a longer-term animal study.

Learn more about how RG7800 can be used to treat SMA.

 

Leave a Comment

Your email address will not be published. Required fields are marked *

Pin It on Pinterest

Share This